Tianan Pharmaceutical Co Stock Market Value
| TNPH Stock | USD 0.01 0.00 0.00% |
| Symbol | Tianan |
Tianan Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Tianan Pharmaceutical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Tianan Pharmaceutical.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Tianan Pharmaceutical on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Tianan Pharmaceutical Co or generate 0.0% return on investment in Tianan Pharmaceutical over 90 days. Tianan Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional Chinese herbal medicines, including pallet... More
Tianan Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Tianan Pharmaceutical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Tianan Pharmaceutical Co upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1308 | |||
| Maximum Drawdown | 317.02 |
Tianan Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tianan Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Tianan Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Tianan Pharmaceutical historical prices to predict the future Tianan Pharmaceutical's volatility.| Risk Adjusted Performance | 0.1171 | |||
| Jensen Alpha | 5.94 | |||
| Total Risk Alpha | 1.29 | |||
| Treynor Ratio | (0.45) |
Tianan Pharmaceutical February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1171 | |||
| Market Risk Adjusted Performance | (0.44) | |||
| Mean Deviation | 10.9 | |||
| Coefficient Of Variation | 751.1 | |||
| Standard Deviation | 38.07 | |||
| Variance | 1449.04 | |||
| Information Ratio | 0.1308 | |||
| Jensen Alpha | 5.94 | |||
| Total Risk Alpha | 1.29 | |||
| Treynor Ratio | (0.45) | |||
| Maximum Drawdown | 317.02 | |||
| Skewness | 7.43 | |||
| Kurtosis | 56.89 |
Tianan Pharmaceutical Backtested Returns
Tianan Pharmaceutical is out of control given 3 months investment horizon. Tianan Pharmaceutical owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.13, which indicates the firm had a 0.13 % return per unit of risk over the last 3 months. We were able to interpolate data for sixteen different technical indicators, which can help you to evaluate if expected returns of 5.07% are justified by taking the suggested risk. Use Tianan Pharmaceutical Risk Adjusted Performance of 0.1171, variance of 1449.04, and Coefficient Of Variation of 751.1 to evaluate company specific risk that cannot be diversified away. Tianan Pharmaceutical holds a performance score of 10 on a scale of zero to a hundred. The entity has a beta of -11.12, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Tianan Pharmaceutical are expected to decrease by larger amounts. On the other hand, during market turmoil, Tianan Pharmaceutical is expected to outperform it. Use Tianan Pharmaceutical mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and day median price , to analyze future returns on Tianan Pharmaceutical.
Auto-correlation | 0.26 |
Poor predictability
Tianan Pharmaceutical Co has poor predictability. Overlapping area represents the amount of predictability between Tianan Pharmaceutical time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Tianan Pharmaceutical price movement. The serial correlation of 0.26 indicates that nearly 26.0% of current Tianan Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.26 | |
| Spearman Rank Test | 0.86 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Tianan Pink Sheet
Tianan Pharmaceutical financial ratios help investors to determine whether Tianan Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tianan with respect to the benefits of owning Tianan Pharmaceutical security.